首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
CALCIUM CHANNEL BLOCKERS COMPRISING TWO BENZHYDRIL MOIETIES
摘要
Certain piperazine substituted compounds are described which are useful in altering calcium channel activity.
申请公布号
CA2521875(A1)
申请公布日期
2004.10.21
申请号
CA20042521875
申请日期
2004.04.08
申请人
NEUROMED TECHNOLOGIES, INC.
发明人
SNUTCH, TERRANCE P.;PAJOUHESH, HOSSEIN;BELARDETTI, FRANCESCO;ZAMPONI, GERALD W.;PAJOUHESH, HASSAN
分类号
A61K31/4468;A61K31/451;A61K31/4515;A61K31/454;A61K31/4545;A61K31/495;A61K31/496;A61K31/498;A61K31/506;A61K31/5375;A61K31/538;A61K31/5415;A61P9/10;A61P25/08;A61P25/22;A61P25/24;A61P29/00;C07D211/14;C07D211/16;C07D211/46;C07D211/58;C07D213/38;C07D277/74;C07D277/82;C07D295/02;C07D295/03;C07D295/185;C07D317/60;C07D401/04;C07D401/14;(IPC1-7):A61K31/495
主分类号
A61K31/4468
代理机构
代理人
主权项
地址
您可能感兴趣的专利
SELBSTHALTENDER STRUMPF.
MIXING AND DELIVERY SYRINGE ASSEMBLY
MONOCLONAL ANTIBODY AGAINST A TUMOUR-ASSOCIATED ANTIGEN, THE ANTIGEN, AN EPITOPE, HYBRIDOMA, DIAGNOSTIC AIDS, VACCINES, NUCLEIC ACID ENCODING THE ANTIBODY (OR PARTS OF IT) AND FUSION PROTEINS
CATALYST PREPARATION METHOD FOR PRODUCTION OF VINYL ACETATE
PROCESS FOR THE PREPARATION OF SUBSTITUTED MALEIMIDES
1-(9,10-DIHYDRO-9,10-METHANOANTHRACEN-9-YLMETHYL)PIPERIDINE-4-OL AND 4-ONE DERIVATIVES; PREPARATORY PROCESSES AND PHARMACEUTICAL COMPOSITIONS
Abdeckung für Fahrzeuge
UROKINASE VARIANTS WITH IMPROVED FIBRINOLYTIC AND THROMBIN-INHIBITING ACTIVITY AND COMPOSITIONS THEREOF
2(1H)-QUINOLONE PHOSPHONIC ACID COMPOUNDS, PREPARATION AND PHARMACEUTICAL COMPOSITIONS
PUCK FOR NON-ICE SURFACE: OUTER RING ATTACHED TO CORE
PAPER CONTAINING SYNTHETIC SILICA AS A FILLER
PREPARATION OF STERILE SODIUM AMOXYCILLIN
WATER HEATER; DETAILS REGARDING TURBULATOR PLACED IN THE INLET WATER AREA
BENZIMIDAZOLE COMPOSITIONS AND ANTHELMINTIC COMPOSITIONS
AUTOMATICALLY CONFIGURABLE OPTICAL DISTRIBUTION SYSTEM
IMPROVED FASTENING MACHINES
PRODUCTION OF ETHER CARBOXYLIC ACIDS AND THEIR SALTS
Schweißband für Kopfbedeckungen
CONICAL MOTION MIXING MACHINE
METHOD OF ATTENUATION OF NERVOUS SYSTEM DAMAGE